(19)
(11) EP 1 465 998 A2

(12)

(88) Date of publication A3:
18.12.2003

(43) Date of publication:
13.10.2004 Bulletin 2004/42

(21) Application number: 03729224.0

(22) Date of filing: 07.01.2003
(51) International Patent Classification (IPC)7: C12N 15/12, C07K 14/47, C12Q 1/68, G01N 33/68, A61K 31/713, A61P 9/00
(86) International application number:
PCT/EP2003/000060
(87) International publication number:
WO 2003/057911 (17.07.2003 Gazette 2003/29)
(84) Designated Contracting States:
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT SE SI SK TR
Designated Extension States:
AL LT LV MK RO

(30) Priority: 08.01.2002 EP 02000153

(71) Applicant: Bayer HealthCare AG
51368 Leverkusen (DE)

(72) Inventors:
  • STROPP, Udo
    42781 Haan (DE)
  • SCHWERS, Stephan
    51145 Köln (DE)
  • KALLABIS, Harald
    51061 Köln (DE)

   


(54) SINGLE NUCLEOTIDE POLYMORPHISMS PREDICTING CARDIOVASCULAR DISEASE AND MEDICATION EFFICACY